KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash from Financing Activities (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Cash from Financing Activities data on record, last reported at -$355.7 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 52.8% year-over-year to -$355.7 million; the TTM value through Dec 2025 reached -$1.2 billion, down 32.67%, while the annual FY2025 figure was -$1.2 billion, 32.67% down from the prior year.
  • Cash from Financing Activities reached -$355.7 million in Q4 2025 per IDXX's latest filing, down from -$313.3 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at -$13.5 million in Q1 2022 and bottomed at -$355.7 million in Q4 2025.
  • Average Cash from Financing Activities over 5 years is -$177.7 million, with a median of -$158.3 million recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: tumbled 41763.32% in 2021, then soared 89.6% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at -$165.8 million in 2021, then increased by 29.61% to -$116.7 million in 2022, then rose by 12.75% to -$101.8 million in 2023, then plummeted by 128.57% to -$232.8 million in 2024, then plummeted by 52.8% to -$355.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$355.7 million in Q4 2025, -$313.3 million in Q3 2025, and -$165.6 million in Q2 2025.